For decades, doctors have known that patients who develop higher than normal blood sugar eventually require medication and ultimately need to take insulin, having progressed to what is known as Type 2, or adult-onset diabetes. So when a natural protein analog known as GLP-1 was found to lower blood sugar levels in laboratory mice, researchers began investigating its effectiveness in diabetes patients in clinical trials. Once again, they found that GLP-1 lowered blood sugar and increased insulin production in patients with Type 2 diabetes. But just how GLP-1 pushes cells to produce more insulin has only been partially understood.
Now, laboratory research conducted at Cedars-Sinai Medical Center has shown that GLP-1 not only stimulates the insulin-making capacity of islet cells in the pancreas, but that the compound actually makes new insulin, increases the growth of new islet cells and prevents overworked islets from dying prematurely. The study, reported in the December issue of the journal, Endocrinology, (available on-line at http://endo.endojournals.org) is the first lab study to apply GLP-1 directly to freshly isolated human islet cells and suggests that GLP-1 may be useful to delay or prevent the onset of Type 2 diabetes.
"Our study shows that GLP-1 is the first compound to actually generate new insulin," said Riccardo Perfetti, M.D., Ph.D., and Director of the outpatient Diabetes Program at Cedars-Sinai Medical Center. "In other words, it doesnt just deplete the islet cell by making it work harder to produce more insulin, but it actually fixes the cells engine."
Insulin, a hormone that controls blood glucose levels, is made by islet cells in the pancreas. But when the islet cells begin to fail, not enough insulin is produced, causing blood sugar levels to get too high. This in turn, causes the islet cells to work harder to produce more insulin, ultimately stressing the cells and causing them to die.
But earlier research had shown that GLP-1 increased insulin production and slowed the rate that islet cells died in laboratory mice, which prompted the researchers at Cedars-Sinai to find out whether GLP-1 could actually preserve the function and viability of actual human islets. They found that GLP-1 worked by delaying damage to the human islets structure and that the life-span of the cells were significantly increased.
"We found that the islet cells were more efficient when treated with GLP-1, because it prompted them to make insulin only when it was needed," said Dr. Perfetti.
In the study, two groups of islets were isolated from the human pancreas and cultured in the laboratory for five days. One group was treated with GLP-1 every 12 hours, while the other group served as a control and was not treated with GLP-1. Glucose was added to the islet cultures at the end of the first, third and fifth day of the study and a test was performed to measure the amount of insulin secreted by the cells.
During the five days that the cells were studied, the investigators found that the islets in both groups maintained their shape and structural integrity for one day. However, a progressive loss to the structure of the cell and the numbers of actual cells was observed among islets not treated with GLP-1, with the number of viable cells reduced by 45 percent by day five of the study. Alternatively, the islets treated with GLP-1, were able to maintain their shape and structural integrity for a longer period of time, with only a 15 percent reduction in viable cells by the end of day five.
"This shows that the addition of GLP-1 had a significant effect on cell viability and inhibited the structural deterioration that is characteristic of cells that are dying," said Dr. Perfetti.
To find out whether GLP-1 was effective to slow down the rate that the islet cells died, the investigators used a specialized staining technique to see how many viable cells remained by day five - or the last day of the study. They found that time was a major factor in both the treated and untreated islets, but that GLP-1 treated cells lived longer, with about 15.5 percent of the untreated cells having died at day 3 as compared to 6.1 percent in the GLP-1 treated cell cultures. On day five of the study, 18.9% of the untreated cells had died, while cell death occurred in only 8.9% of the GLP-1 treated cells.
In addition, when the investigators added glucose to the islet cell cultures to determine whether GLP-1 would stimulate the cells to secrete insulin, they found that GLP-1 treated cells were more sensitive to glucose and secreted more insulin than the untreated islet cells.
"All together, this study shows that GLP-1s ability to prevent islet cells from dying could possibly be used to prevent Type 2 diabetes," said Dr. Perfetti.
This study was sponsored by the Max Factor Family Foundation.
Cedars-Sinai Medical Center is one of the largest non-profit academic medical centers in the Western United States. For the fifth straight two-year period, Cedars-Sinai has been named Southern Californias gold standard in health care in an independent survey. Cedars-Sinai is internationally renowned for its diagnostic and treatment capabilities and its broad spectrum of programs and services, as well as breakthrough in biomedical research and superlative medical education. Named one of the 100 "Most Wired" hospitals in health care in 2001, the Medical Center ranks among the top 10 non-university hospitals in the nation for its research activities.
Sandy Van | Van Communications
Investigators may unlock mystery of how staph cells dodge the body's immune system
22.09.2017 | Cedars-Sinai Medical Center
Monitoring the heart's mitochondria to predict cardiac arrest?
21.09.2017 | Boston Children's Hospital
Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.
A warming planet
Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.
The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...
Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...
Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!
When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...
For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.
Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...
19.09.2017 | Event News
12.09.2017 | Event News
06.09.2017 | Event News
22.09.2017 | Life Sciences
22.09.2017 | Medical Engineering
22.09.2017 | Physics and Astronomy